Cultured AFB Antitubercular DST Cycloserine Test
Comprehensive Tuberculosis Drug Sensitivity Testing
The Cultured AFB Antitubercular DST Cycloserine Test represents a critical advancement in the management of drug-resistant tuberculosis. This specialized diagnostic procedure evaluates the effectiveness of cycloserine, a second-line antitubercular medication, against Mycobacterium tuberculosis complex strains. As tuberculosis continues to pose significant public health challenges globally, particularly with the emergence of multidrug-resistant (MDR-TB) and extensively drug-resistant (XDR-TB) strains, precise drug sensitivity testing becomes increasingly vital for successful treatment outcomes.
What This Test Measures and Detects
This sophisticated diagnostic test specifically measures the sensitivity of Mycobacterium tuberculosis complex to cycloserine, determining whether the bacterial strain is susceptible or resistant to this important second-line antitubercular drug. The test utilizes automated fluorescent technology to provide highly accurate results by:
- Evaluating bacterial growth inhibition in the presence of cycloserine
- Determining minimum inhibitory concentrations (MICs)
- Identifying specific resistance patterns to cycloserine
- Providing quantitative data for treatment optimization
Who Should Consider This Test
This specialized test is recommended for patients experiencing specific clinical scenarios related to tuberculosis treatment:
- Patients with confirmed tuberculosis who have failed first-line treatment regimens
- Individuals diagnosed with multidrug-resistant tuberculosis (MDR-TB)
- Patients showing persistent symptoms despite ongoing TB treatment
- Those with known exposure to drug-resistant tuberculosis strains
- Patients requiring second-line TB treatment due to medication intolerance
- Individuals with recurrent tuberculosis infections
- Patients from regions with high rates of drug-resistant TB
Clinical Benefits of Drug Sensitivity Testing
Undergoing the Cultured AFB Antitubercular DST Cycloserine Test provides numerous clinical advantages for both patients and healthcare providers:
- Personalized Treatment Planning: Enables physicians to create customized treatment regimens based on specific drug sensitivity profiles
- Enhanced Treatment Efficacy: Helps select the most effective medications, improving treatment success rates
- Reduced Side Effects: Avoids unnecessary exposure to ineffective medications and their associated adverse effects
- Cost-Effective Care: Prevents wasted resources on ineffective treatments and reduces overall healthcare costs
- Public Health Protection: Contributes to controlling the spread of drug-resistant tuberculosis strains
- Improved Patient Outcomes: Leads to faster recovery times and reduced risk of treatment failure
Understanding Your Test Results
Interpreting the results of your Cultured AFB Antitubercular DST Cycloserine Test requires professional medical expertise, but here’s general guidance on what your results may indicate:
- Susceptible Result: The tuberculosis strain is effectively inhibited by cycloserine, making this medication a viable treatment option
- Resistant Result: The bacterial strain shows resistance to cycloserine, indicating the need for alternative treatment approaches
- Intermediate Sensitivity: The bacteria show partial sensitivity, which may require combination therapy or adjusted dosing
Your physician will interpret these results in the context of your complete clinical picture, including other drug sensitivity results, medical history, and current symptoms to develop the most effective treatment strategy.
Test Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Cultured AFB Antitubercular DST Cycloserine Test | $100 USD | $162 USD |
Nationwide Testing Availability
We provide comprehensive tuberculosis testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee. Our state-of-the-art facilities ensure consistent, high-quality testing standards nationwide.
Take Control of Your Tuberculosis Treatment
Don’t let drug-resistant tuberculosis compromise your health and recovery. The Cultured AFB Antitubercular DST Cycloserine Test provides the critical information needed to develop an effective, personalized treatment plan. With our discounted price of $100 USD and comprehensive nationwide coverage, accessing this advanced diagnostic testing has never been more convenient or affordable.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your test and take the first step toward effective tuberculosis management.

